Pharmacogenomics: A Genetic Approach to Drug Development and Therapy
Pharmaceuticals · 13.07.2024 · 17 (7) · 940
DOI: 10.3390/ph17070940 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 13.07.2024. Verfasst von Rowaid Qahwaji und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 22254, Saudi Arabia. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The majority of the well-known pharmacogenomics research used in the medical sciences contributes to our understanding of medication interactions. It has a significant impact on treatment and drug development. The broad use of pharmacogenomics is required for the progress of therapy. The main focus is on how genes and an intricate gene system affect the body’s reaction to medications. Novel biomarkers that help identify a patient group that is more or less likely to respond to a certain medication have been discovered as a result of recent developments in the field of clinical therapeutics. It aims to improve customized therapy by giving the appropriate drug at the right dose at the right time and making sure that the right prescriptions are issued. A combination of genetic, environmental, and patient variables that impact the pharmacokinetics and/or pharmacodynamics of medications results in interindividual variance in drug response. Drug development, illness susceptibility, and treatment efficacy are all impacted by pharmacogenomics. The purpose of this work is to give a review that might serve as a foundation for the creation of new pharmacogenomics applications, techniques, or strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 22254, Saudi Arabia.
- Hematology Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
- College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Ar Rimayah, Riyadh 14611, Saudi Arabia.
- King Abdullah International Medical Research Center, Jeddah 22384, Saudi Arabia.
- Department of Biomedical Laboratory Science, Faculty of Natural Sciences, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway.
ORCID-Profile: Ibraheem Ashankyty, Naif S Sannan, Mohannad S Hazzazi, Mohammad Mobashir
Zitieren
APA
Qahwaji, R., Ashankyty, I., Sannan, N. S., Hazzazi, M. S., Basabrain, A. A., & Mobashir, M. (2024). Pharmacogenomics: A Genetic Approach to Drug Development and Therapy. Pharmaceuticals, 17(7), 940. https://doi.org/10.3390/ph17070940
Vancouver
Qahwaji R, Ashankyty I, Sannan NS, Hazzazi MS, Basabrain AA, Mobashir M. Pharmacogenomics: A Genetic Approach to Drug Development and Therapy. Pharmaceuticals. 2024;17(7):940. doi:10.3390/ph17070940
BibTeX
@article{Qahwaji2024,
author = {Qahwaji, Rowaid and Ashankyty, Ibraheem and Sannan, Naif S and Hazzazi, Mohannad S and Basabrain, Ammar A and Mobashir, Mohammad},
title = {Pharmacogenomics: A Genetic Approach to Drug Development and Therapy},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {7},
pages = {940},
doi = {10.3390/ph17070940}
}
EUVIMED